These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1894585)

  • 21. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
    Zaja F; Iacona I; Masolini P; Russo D; Sperotto A; Prosdocimo S; Patriarca F; de Vita S; Regazzi M; Baccarani M; Fanin R
    Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Membrane autoantibodies in systemic lupus erythematosus: a case of autoimmune hemolytic anemia, antiphospholipid antibodies, and transient acquired activated protein C resistance.
    Staropoli JF; Van Cott EM; Makar RS
    Transfusion; 2008 Nov; 48(11):2435-41. PubMed ID: 18673345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
    Carella AM; Chimirri F; Podestà M; Pitto A; Piaggio G; Dejana A; Lerma E; Pollicardo N; Vassallo F; Soracco M; Benvenuto F; Valbonesi M; Carlier P; Vimercati R; Prencipe E; Gatti AM; Ferrara RA; Incagliato M; Florio G; Frassoni F
    Bone Marrow Transplant; 1996 Feb; 17(2):201-5. PubMed ID: 8640167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful treatment of anemia in idiopathic myelofibrosis with recombinant human erythropoietin.
    Hasselbalch HC; Clausen NT; Jensen BA
    Am J Hematol; 2002 Jun; 70(2):92-9. PubMed ID: 12111781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Special Education: Aplastic Anemia.
    Teramura M; Mizoguchi H
    Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoimmune hemolytic anemia during alpha interferon treatment in nine patients with hematological diseases.
    Andriani A; Bibas M; Callea V; De Renzo A; Chiurazzi F; Marcenò R; Musto P; Rotoli B
    Haematologica; 1996; 81(3):258-60. PubMed ID: 8767532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrastructure of bone marrow tissue in so-called primary (idiopathic) myelofibrosis-osteomyelosclerosis (agnogenic myeloid metaplasia). II. The myeloid stroma (hematopoietic microenvironment).
    Thiele J; Schmidt J; Sander C; Fischer R
    J Submicrosc Cytol Pathol; 1991 Jan; 23(1):109-21. PubMed ID: 2036622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subtotal splenectomy for treatment of patients with myelofibrosis and myeloid metaplasia.
    Petroianu A
    Int Surg; 1996; 81(2):177-9. PubMed ID: 8912088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spontaneous remission of agnogenic myeloid metaplasia in a splenectomized patient: a case report with erythrokinetic studies.
    Shimizu K; Hotta T
    Acta Haematol; 1990; 83(1):45-8. PubMed ID: 2105570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late onset haemolysis and red cell autoimmunisation after allogeneic bone marrow transplant.
    Chen FE; Owen I; Savage D; Roberts I; Apperley J; Goldman JM; Laffan M
    Bone Marrow Transplant; 1997 Mar; 19(5):491-5. PubMed ID: 9052917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Agnogenic myelofibrosis in children--a case report and review of the literature.
    Hamazaki M; Mugishima H
    Acta Pathol Jpn; 1981 Jan; 31(1):143-52. PubMed ID: 7234418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The reversal of myelofibrosis associated with chronic myelogenous leukemia after allogeneic bone marrow transplantation.
    Oblon DJ; Elfenbein GJ; Braylan RC; Jones J; Weiner RS
    Exp Hematol; 1983 Aug; 11(7):681-5. PubMed ID: 6350032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon in the treatment of myeloproliferative diseases.
    Silver RT
    Semin Hematol; 1990 Jul; 27(3 Suppl 4):6-14. PubMed ID: 2115694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormal (marker) chromosomes in two patients with acute myelofibrosis.
    Mitus WJ; Coleman N; Kiossoglou KA
    Arch Intern Med; 1969 Feb; 123(2):192-7. PubMed ID: 5763618
    [No Abstract]   [Full Text] [Related]  

  • 35. Danazol therapy in autoimmune hemolytic anemia associated with systemic lupus erythematosus.
    Chan AC; Sack K
    J Rheumatol; 1991 Feb; 18(2):280-2. PubMed ID: 2023224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Demonstration of two distinct antibodies in autoimmune hemolytic anemia with reticulocytopenia and red cell aplasia.
    Mangan KF; Besa EC; Shadduck RK; Tedrow H; Ray PK
    Exp Hematol; 1984 Nov; 12(10):788-93. PubMed ID: 6439569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment approaches in myelofibrosis with myeloid metaplasia: the old and the new.
    Tefferi A
    Semin Hematol; 2003 Jan; 40(1 Suppl 1):18-21. PubMed ID: 12682877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chromosome deletion [46,XX,del(20)(q11)] in agnogenic myeloid metaplasia.
    Findley L; Kurnick JE; Peakman DC; Robinson A
    Hum Genet; 1979 Mar; 47(2):207-11. PubMed ID: 437786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Idiopathic acquired sideroblastic anemia terminating in acute myelofibrosis: case report and review of leterature.
    Yeung K; Trowbridge AA
    Cancer; 1977 Jan; 39(1):359-65. PubMed ID: 318917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. alpha-Interferon in myelofibrosis: a case report.
    Dalla KP; Zeigler ZR; Shadduck RK
    Br J Haematol; 1994 Mar; 86(3):654-6. PubMed ID: 8043450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.